Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Administering Nalbuphine 0.1MG/KG intravenously: dose 0.1 mg/kg of Nalbuphine WILL be given intravenously AND SHIVERING WILL BE ASSESSED AT 15 MIN INTERVALS TILL THE END OF SURGERY
Con
Sponsors
ESI medical college and hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patientâ??s belonging to ASA 1 and 2 Scheduled for infra umbilical surgeries Patientâ??s without having any comorbidities
Exclusion criteria
Exclusion criteria: Patients belonging to ASA3 or more Pregnant women Patients less than 18 years Patient not willing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Shivering score Timepoint: T1: 10 minutes after spinal anesthesia T2: 20 minutes after spinal anesthesiaT3 within 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side effects - To assess any side effects like respiratory depression, urinary retention, nausea, vomiting, sedation, pruritus, drowsiness, hallucination and delirium will be noted. Timepoint: T1: Post operatively every 2nd hourly till 24 hours | — |
Countries
India
Contacts
Public ContactDr Gayatri CK
ESI medical college and hospital
Outcome results
None listed